Pursuing the Triple Aim in Hotspotters: Identification and Integrated Care
Launched by LEIDEN UNIVERSITY MEDICAL CENTER · May 17, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
People with complex problems on multiple life domains, so called 'hotspotters', receive fragmented care. This is difficult to manage by patients and care providers , leading to little effect of care and persistent unmet needs. The accumulation and complexity of problems often leads to high medical expenses. Next to their high medical spending levels, hotspotters´ experiences with the healthcare system are low as the healthcare system is not (yet) successful in dealing with their needs. Interventions aimed at the complex situation of hotspotters in our current healthcare system might benefit...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patients are ≥ 18yrs
- • The patients are registered within one of the participating GP practices.
- • Patients with at least two acute care encounters in the past 12 months. Acute care encounter is defined as an encounter with out-of-hours GP service, emergency care or acute mental health care.Patients have problems registered in the GP Information system on at least two out of three of the following domains: somatic, mental or social. Somatic problems is having at least one ICPC code on the problem list. Mental problems is having at least one ICPC code from the "P"-chapter on either the problem list, as a reason for encounter, and/or having medication prescribed related to mental health problems. Social problems is having at least one ICPC code from the "Z"-chapter or as reason for encounter, and/or having medication prescribed related to social problems.
- Exclusion Criteria:
- • The patient is terminal.
- • The patient is living in a residential home.
- • The patient has dementia or a disability that prevents them from communicating effectively.The patient already has experience with the positive health tool.
- • The patient is not competent to make decisions concerning their health. This wil be assessed by the patient's own general practitioner.
- • Veto of the GP
About Leiden University Medical Center
Leiden University Medical Center (LUMC) is a prominent academic medical center located in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and high-quality patient care. As a clinical trial sponsor, LUMC focuses on translating scientific discoveries into effective therapies, fostering collaborations between researchers, clinicians, and industry partners. The center is dedicated to conducting rigorous clinical studies across various medical fields, ensuring adherence to ethical standards and regulatory requirements while prioritizing patient safety and outcomes. Through its multidisciplinary approach, LUMC aims to contribute significantly to the understanding and treatment of complex health conditions, driving progress in personalized medicine and improving global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leiden, , Netherlands
Patients applied
Trial Officials
Rimke Vos, dr
Principal Investigator
Leiden University medical centre, health campus The Hague
Marc Bruijnzeels, dr
Principal Investigator
Leiden University medical centre, health campus The Hague
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported